PCMI
XGN icon

Paradigm Capital Management Inc’s Exagen XGN Stock Holding History

Paradigm Capital Management Inc’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-81,189
Closed -$220K – 149
2022
Q3 		$220K Hold
81,189
– – 0.02% 136
2022
Q2 		$466K Buy
81,189
+24,289
+43% +$141K 0.03% 126
2022
Q1 		$457K Buy
56,900
+15,234
+37% +$131K 0.02% 131
2021
Q4 		$485K Buy
+41,666
New +$488K 0.02% 139

Other funds holding XGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Paradigm Capital Management Inc's XGN Position: Q4 2022 in Review

Paradigm Capital Management Inc sold out of Exagen (XGN) in Q4 2022, closing a stake of 81,189 shares — an estimated $220K sold.

Paradigm Capital Management Inc first reported a position in XGN in Q4 2021 and held it in 4 quarters. The position peaked at $485K in Q4 2021. 31 funds tracked by Wall St. Rank hold XGN as of Q4 2022.

  • Paradigm Capital Management Inc reported no remaining Exagen position as of Q4 2022 after selling out during the quarter.
  • Paradigm Capital Management Inc sold 81,189 Exagen shares in Q4 2022, an estimated $220K.
  • Paradigm Capital Management Inc first reported a position in Exagen in Q4 2021 and held it in 4 quarters.
  • Paradigm Capital Management Inc's Exagen position peaked at $485K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Exagen as of Q4 2022.

Based on Paradigm Capital Management Inc's 13F filing for Q4 2022, filed 3 Feb 2023.